Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Vilaprisan

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Vilaprisan
Clinical data
Other namesBAY-1002670; 17β-Hydroxy-11β-[4-(methylsulfonyl)phenyl]-17α-(1,1,2,2,2-pentafluoroethyl)estra-4,9-dien-3-one
Routes of
administration
By mouth
Drug classSelective progesterone receptor modulator
Identifiers
  • (8S,11R,13S,14S,17S)-17-Hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC27H29F5O4S
Molar mass544.58 g·mol−1
3D model (JSmol)
  • C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C(C(F)(F)F)(F)F)O)C5=CC=C(C=C5)S(=O)(=O)C
  • InChI=1S/C27H29F5O4S/c1-24-14-21(15-3-7-18(8-4-15)37(2,35)36)23-19-10-6-17(33)13-16(19)5-9-20(23)22(24)11-12-25(24,34)26(28,29)27(30,31)32/h3-4,7-8,13,20-22,34H,5-6,9-12,14H2,1-2H3/t20-,21+,22-,24-,25-/m0/s1
  • Key:JUFWQQVHQFDUOD-ANRPBIDPSA-N

Vilaprisan (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name) (developmental code nameBAY-1002670) is asynthetic andsteroidalselective progesterone receptor modulator (SPRM) which is under development byBayer HealthCare Pharmaceuticals for the treatment ofendometriosis anduterine fibroids.[1][2][3] It is apotent and highlyselectivepartial agonist of theprogesterone receptor (PR).[4][2][3] As of 2017, the drug is inphase IIclinical trials for the aforementioned indications.[1]

See also

[edit]

References

[edit]
  1. ^ab"Vilaprisan - Bayer HealthCare Pharmaceuticals - AdisInsight".
  2. ^abWhitaker LH, Williams AR, Critchley HO (2014). "Selective progesterone receptor modulators".Curr. Opin. Obstet. Gynecol.26 (4):237–42.doi:10.1097/GCO.0000000000000082.PMID 24950125.S2CID 37474964.
  3. ^abPluchino N, Freschi L, Wenger JM, Streuli I (2016). "Innovations in classical hormonal targets for endometriosis".Expert Rev Clin Pharmacol.9 (2):317–27.doi:10.1586/17512433.2016.1129895.PMID 26645363.S2CID 8624056.
  4. ^Schütt B, Kaiser A, Schultze-Mosgau MH, Seitz C, Bell D, Koch M, Rohde B (2016)."Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women".Hum. Reprod.31 (8):1703–12.doi:10.1093/humrep/dew140.PMID 27288475.

External links

[edit]


PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
Stub icon

This article about asteroid is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Vilaprisan&oldid=1135328393"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp